(1) As used in this section, unless the context otherwise requires, "kratom product" means any product or ingredient containing:(a) Any part of the leaf of the mitragyna speciosa plant if the plant contains the alkaloid mitragynine or 7-hydroxymitragynine; or(b) A synthetic material that contains the alkaloid mitragynine or 7-hydroxymitragynine.(3) Effective July 1, 2024, a person shall not:(a) Knowingly prepare, distribute, advertise, sell, or offer to sell a kratom product that is adulterated with fentanyl or any other controlled substance listed in part 2 of article 18 of title 18;(b) Sell a kratom product that does not have a label that clearly sets forth: (I) The identity and address of the manufacturer; and(II) The full list of ingredients in the kratom product;(c) Knowingly prepare, distribute, advertise, sell, or offer to sell a kratom product to a person under twenty-one years of age; or(d) Display or store kratom products in a retail location in a manner that will allow the products to be accessed by individuals under twenty-one years of age.(4) The executive director may promulgate rules that are necessary for the enforcement of subsection (3) of this section.Added by 2022 Ch. 251, § 2, eff. 8/10/2022.Subsection (2)(c) provided for the repeal of subsection (2), effective July 1, 2023. (See L. 2022, p. 1838.)
2022 Ch. 251, was passed without a safety clause. See Colo. Const. art. V, § 1(3). For the legislative declaration in SB 22-120, see section 1 of chapter 251, Session Laws of Colorado 2022.